{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:40Z","timestamp":1789143100323,"version":"build-2803163510"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pharmacist services demonstrate a positive impact on healthcare delivery, patient outcomes, and cost of care. Translating this evidence into sustainable funding models demands significant change in healthcare policy and payment that accounts for institutional constraints, payment structures, and scalability requirements. Meanwhile, the gap grows between the positive impact of pharmacist services and reimbursement limited to narrowly defined services or drug product costs. Lack of federally designated provider status and payer-imposed cost containment strategies threaten the financial sustainability of pharmacist services. Future solutions include innovative value-based payment with quality-driven reimbursement, comprehensive medication and care management, and shared financial savings linked to outcomes. Priority funding areas using a shared-savings model include acute and chronic care service lines that cater to high-acuity patients who require high-cost medications and experience frequent care transitions. This model is based on reductions in medication costs, adverse drug-related outcomes, length of stay, and readmissions. A call to action is proposed, focused on policy changes in provider status, adequate payer reimbursement, improving current fee-for-service models and shifting payment models to value-based payment, and removing misaligned financial strategies.<\/jats:p>","DOI":"10.1093\/haschl\/qxag204","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:52:55Z","timestamp":1786017175000},"source":"Crossref","is-referenced-by-count":0,"title":["Building on the 2025 National Academies Pharmacy Workshop: health systems financially supported pharmacist roles"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9643-836X","authenticated-orcid":false,"given":"Vinita B","family":"Pai","sequence":"first","affiliation":[{"name":"College of Pharmacy, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0501-6490","authenticated-orcid":false,"given":"Kelli","family":"Barnes","sequence":"additional","affiliation":[{"name":"College of Pharmacy, The Ohio State University , Columbus, OH 43210 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-5262","authenticated-orcid":false,"given":"Sarah J","family":"Billups","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz , Aurora, CO 80045 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-6547","authenticated-orcid":false,"given":"Marie","family":"Chisholm-Burns","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmacy, Oregon Health & Science University , Corvalis, OR 97331 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Heil","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences and Health Outcomes Research, University of Maryland School of Pharmacy , Baltimore, MD 21201 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2363-4431","authenticated-orcid":false,"given":"Alice N","family":"Hemenway","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois Chicago, Retzky College of Pharmacy , Rockford, IL 61107 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Kliethermes","sequence":"additional","affiliation":[{"name":"American Society of Health-System Pharmacists, Bethesda, MD 20814 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-4713","authenticated-orcid":false,"given":"Lisa","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-0884","authenticated-orcid":false,"given":"Jennifer","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California , San Diego, La Jolla, CA 92093 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lu","sequence":"additional","affiliation":[{"name":"University of South Carolina College of Pharmacy , Columbia, SC 29208 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-0234","authenticated-orcid":false,"given":"Candis M","family":"Morello","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California , San Diego, La Jolla, CA 92093 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-3386","authenticated-orcid":false,"given":"Nkem P","family":"Nonyel","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy Sciences, Howard University College of Pharmacy , Washington, DC 20059 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-4716","authenticated-orcid":false,"given":"Anthony W","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Investigational Medicine, Department of Pharmacy, Center for Pharmacy Innovation and Outcomes , Geisinger College of Health Sciences, Danville, PA 17822 ,","place":["United States"]},{"name":"Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota , Duluth, MN 55812 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4318-7165","authenticated-orcid":false,"given":"Douglas","family":"Slain","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy , Pittsburgh, PA 15261 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-5217","authenticated-orcid":false,"given":"Candy","family":"Tsourounis","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7157-9396","authenticated-orcid":false,"given":"Ryan","family":"Wargo","sequence":"additional","affiliation":[{"name":"Legacy Health , Portland, OR 97210 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4946-7504","authenticated-orcid":false,"given":"Kristin","family":"Wiisanen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rosalind Franklin University of Medicine and Sciences , North Chicago, IL 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-3264","authenticated-orcid":false,"given":"Linda","family":"Awdishu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California , San Diego, La Jolla, CA 92093 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"9","key":"2026091111365260200_qxag204-B1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1060028018765159","article-title":"Cost of prescription drug-related morbidity and mortality","volume":"52","author":"Watanabe","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2026091111365260200_qxag204-B2","author":"Chen"},{"issue":"18","key":"2026091111365260200_qxag204-B3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/ajhp\/zxaf150","article-title":"ASHP national survey of pharmacy practice in hospital settings: clinical services and workforce\u20142024","volume":"82","author":"Pedersen","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"18","key":"2026091111365260200_qxag204-B4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2146\/ajhp110566","article-title":"Creating pharmacy staffing-to-demand models: predictive tools used at two institutions","volume":"69","author":"Krogh","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"2026091111365260200_qxag204-B5","author":"National Academies of Sciences, Engineering, and Medicine"},{"key":"2026091111365260200_qxag204-B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17226\/29229","volume-title":"Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care: Proceedings of a Workshop","author":"National Academies of Sciences, Engineering, and Medicine","year":"2025"},{"key":"2026091111365260200_qxag204-B7","author":"Vespa"},{"issue":"1","key":"2026091111365260200_qxag204-B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12963-018-0166-4","article-title":"Projection of the future diabetes burden in the United States through 2060","volume":"16","author":"Lin","year":"2018","journal-title":"Popul Health Metr"},{"issue":"1","key":"2026091111365260200_qxag204-B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the heart failure society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"1","key":"2026091111365260200_qxag204-B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1681\/asn.2018050531","article-title":"Projecting ESRD incidence and prevalence in the United States through 2030","volume":"30","author":"Mccullough","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2026091111365260200_qxag204-B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40266-019-00726-0","article-title":"Frequency and predictors of polypharmacy in US medicare patients: a cross-sectional analysis at the patient and physician levels","volume":"37","author":"Ellenbogen","year":"2019","journal-title":"Drugs Aging"},{"key":"2026091111365260200_qxag204-B12","author":"Centers for Disease Control and Prevention and National Association of Chronic Disease Directors"},{"key":"2026091111365260200_qxag204-B13","doi-asserted-by":"publisher","author":"National Academies of Sciences, Engineering, and Medicine","DOI":"10.17226\/25983"},{"key":"2026091111365260200_qxag204-B14","volume-title":"The Complexities of Physician Supply and Demand: Projections from 2021 to 2036","author":"Association of American Medical Colleges (AAMC)","year":"2024"},{"key":"2026091111365260200_qxag204-B15","doi-asserted-by":"publisher","first-page":"10600280261458912","DOI":"10.1177\/10600280261458912","article-title":"Optimizing time in therapeutic range in patients with HeartMate 3: pharmacist-led anticoagulation using pharmacogenetics of warfarin","author":"Gregor","year":"2026","journal-title":"Ann Pharmacother"},{"issue":"8","key":"2026091111365260200_qxag204-B16","doi-asserted-by":"publisher","DOI":"10.1056\/cat.25.0416","article-title":"Cancer immunotherapy stewardship\u2014cost-neutral, patient-centered dosing to increase infusion center efficiency","volume":"7","author":"Moeller","year":"2026","journal-title":"NEJM Catal Innov Care Deliv"},{"issue":"7","key":"2026091111365260200_qxag204-B17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/curroncol32070402","article-title":"Optimizing adjuvant care in early breast cancer: multidisciplinary strategies and innovative models from Canadian centers","volume":"32","author":"Chan","year":"2025","journal-title":"Curr Oncol"},{"issue":"7","key":"2026091111365260200_qxag204-B18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.18553\/jmcp.2021.27.7.882","article-title":"Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy","volume":"27","author":"Peter","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"2026091111365260200_qxag204-B19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12872-021-02178-0","article-title":"Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial","volume":"21","author":"\u00d6stbring","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"2026091111365260200_qxag204-B20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/00185787231213807","article-title":"Benefits of accepting infectious diseases pharmacist recommendations: a 5-year outcome study in a multihospital system","volume":"59","author":"Babiarz","year":"2023","journal-title":"Hosp Pharm"},{"issue":"1","key":"2026091111365260200_qxag204-B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311707","article-title":"Economic impact and clinical benefits of clinical pharmacy interventions: a six-year multi-center study using an innovative medication management tool","volume":"20","author":"Alsetohy","year":"2025","journal-title":"PLoS One"},{"issue":"3","key":"2026091111365260200_qxag204-B22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.18553\/jmcp.2017.23.3.318","article-title":"Estimated cost-effectiveness, cost benefit, and risk reduction associated with an endocrinologist-pharmacist diabetes intense medical management \u201ctune-up\u201d clinic","volume":"23","author":"Hirsch","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"2026091111365260200_qxag204-B23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/ccm.0000000000003830","article-title":"Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis*","volume":"47","author":"Lee","year":"2019","journal-title":"Crit Care Med"},{"issue":"1","key":"2026091111365260200_qxag204-B24","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1093\/ajhp\/zxaf113","article-title":"Cost analysis of a clinical pharmacist-led multidisciplinary iron deficiency treatment clinic for patients with heart failure or pulmonary hypertension","volume":"83","author":"Pathan","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"2026091111365260200_qxag204-B25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1200\/op-25-00333","article-title":"Remote clinical pharmacist impact on reducing total cost of care in enhancing oncology model-enrolled oncology practices","volume":"22","author":"Kendzierski","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"2026091111365260200_qxag204-B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jhm.2493","article-title":"Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH study)","volume":"11","author":"Phatak","year":"2015","journal-title":"J Hosp Med"},{"issue":"6","key":"2026091111365260200_qxag204-B27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/cir.0000000000001141","article-title":"Person-centered models for cardiovascular care: a review of the evidence: a scientific statement from the American Heart Association","volume":"148","author":"Rossi","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"2026091111365260200_qxag204-B28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.japh.2018.11.005","article-title":"Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up","volume":"59","author":"Wright","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"7","key":"2026091111365260200_qxag204-B29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ajhp\/zxaa012","article-title":"Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes","volume":"77","author":"Bae-Shaaw","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"2026091111365260200_qxag204-B30","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.18553\/jmcp.2020.26.12.1558","article-title":"Pharmacists providing care in statewide physician organizations: findings from the Michigan pharmacists transforming care and quality collaborative","volume":"26","author":"Coe","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"2026091111365260200_qxag204-B31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ajhp\/zxad045","article-title":"Assessing the impact of a payor-funded embedded clinical pharmacist on patient and provider satisfaction in a private primary care practice","volume":"80","author":"Gadd","year":"2023","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"2026091111365260200_qxag204-B32","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1002\/phar.1215","article-title":"Improving care transitions: current practice and future opportunities for pharmacists","volume":"32","author":"American College of Clinical Pharmacy","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"18","key":"2026091111365260200_qxag204-B33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2146\/ajhp161052","article-title":"Pharmacists supporting population health in patient-centered medical homes","volume":"74","author":"Coe","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"2026091111365260200_qxag204-B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18553\/jmcp.2022.28.1.85","article-title":"Pharmacists as accessible health care providers: quantifying the opportunity","volume":"28","author":"Valliant","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"key":"2026091111365260200_qxag204-B35","author":"Wettergreen"},{"issue":"2","key":"2026091111365260200_qxag204-B36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11096-024-01843-6","article-title":"Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory","volume":"47","author":"Clarenne","year":"2024","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2026091111365260200_qxag204-B37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s11096-018-0733-6","article-title":"Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital","volume":"40","author":"Jourdan","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"2026091111365260200_qxag204-B38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10096-017-3166-6","article-title":"Evidence of clinical and economic impact of pharmacist interventions related to antimicrobials in the hospital setting","volume":"37","author":"Leache","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"2026091111365260200_qxag204-B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/ajhp\/zxac340","article-title":"A cost avoidance study of critical care pharmacists\u2019 interventions in a tertiary institution in Singapore","volume":"80","author":"Chan","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"2026091111365260200_qxag204-B40","doi-asserted-by":"publisher","DOI":"10.1097\/cce.0000000000000594","article-title":"PHarmacist avoidance or reductions in medical costs in CRITically ill adults: PHARM-CRIT study","volume":"3","author":"Rech","year":"2021","journal-title":"Crit Care Explor"},{"issue":"9","key":"2026091111365260200_qxag204-B41","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/ccm.0000000000005585","article-title":"Impact of pharmacists to improve patient care in the critically ill: a large multicenter analysis using meaningful metrics with the medication regimen complexity-ICU (MRC-ICU) score*","volume":"50","author":"Sikora","year":"2022","journal-title":"Crit Care Med"},{"issue":"9","key":"2026091111365260200_qxag204-B42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jac5.2008","article-title":"State of the union: a review of state-based laws and regulations supporting pharmacist payment for clinical services","volume":"7","author":"Hughes","year":"2024","journal-title":"J Am Coll Clin Pharm"},{"issue":"12","key":"2026091111365260200_qxag204-B43","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.18553\/jmcp.2018.24.12.1273","article-title":"Incident-to billing for pharmacists","volume":"24","author":"Dietrich","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2026091111365260200_qxag204-B44","author":"AMCP Board of Directors"},{"issue":"5","key":"2026091111365260200_qxag204-B45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jac5.1951","article-title":"Identifying ideal pharmacist-to-patient ratios for the successful provision of clinical pharmacy services","volume":"7","author":"Martello","year":"2024","journal-title":"J Am Coll Clin Pharm"},{"issue":"4","key":"2026091111365260200_qxag204-B46","doi-asserted-by":"publisher","first-page":"e863","DOI":"10.1097\/ccm.0000000000006605","article-title":"ICU patient-to-pharmacist ratios: a prospective, multicenter time-motion study","volume":"53","author":"Buckley","year":"2025","journal-title":"Crit Care Med"},{"issue":"3","key":"2026091111365260200_qxag204-B47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/ajhp\/zxz291","article-title":"ASHP guidelines on pharmacy services in solid organ transplantation","volume":"77","author":"Maldonado","year":"2019","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"2026091111365260200_qxag204-B48","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.3716","article-title":"Outcomes of the 340B drug pricing program","volume":"4","author":"Knox","year":"2023","journal-title":"JAMA Health Forum"},{"issue":"17","key":"2026091111365260200_qxag204-B49","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.2022.5959","article-title":"Risks to the 340B drug pricing program related to manufacturer restrictions on drug availability","volume":"327","author":"Knox","year":"2023","journal-title":"JAMA"},{"key":"2026091111365260200_qxag204-B50","author":"Gerlach"},{"key":"2026091111365260200_qxag204-B51","author":"American Pharmacists Association"},{"key":"2026091111365260200_qxag204-B52","first-page":"5","volume-title":"American Pharmacists Association Billing Primer: A pharmacist's guide to Outpatient fee-for-Service Billing","author":"Somma","year":"2019"},{"issue":"9","key":"2026091111365260200_qxag204-B53","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1093\/ajhp\/zxae314","article-title":"Assessing the utilization of current procedural terminology codes in pharmacists\u2019 services using MarketScan data","volume":"82","author":"Rawal","year":"2024","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"2026091111365260200_qxag204-B54","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/jac5.70134","article-title":"National assessment of reimbursement models for clinical faculty services in academic pharmacy practice","volume":"8","author":"Gums","year":"2025","journal-title":"J Am Coll Clin Pharm"},{"issue":"8","key":"2026091111365260200_qxag204-B55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.26857","article-title":"Potential US health care savings based on clinician views of feasible site-of-care shifts","volume":"7","author":"Sahni","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026091111365260200_qxag204-B56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1331\/japha.2009.07158","article-title":"Evaluation of pharmacists\u2019 barriers to the implementation of medication therapy management services","volume":"49","author":"Lounsbery","year":"2009","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026091111365260200_qxag204-B57","author":"Traynor"},{"issue":"2","key":"2026091111365260200_qxag204-B58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcjq.2017.07.007","article-title":"The expanding role of antimicrobial stewardship programs in hospitals in the United States: lessons learned from a multisite qualitative study","volume":"44","author":"Kapadia","year":"2018","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2026091111365260200_qxag204-B59","author":"Electronic Code of Federal Regulations"},{"key":"2026091111365260200_qxag204-B60","author":"Poore"},{"issue":"6","key":"2026091111365260200_qxag204-B61","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1177\/08971900221116684","article-title":"The impact of pharmacists engaged in collaborative practice agreements in the United States","volume":"36","author":"Kerelos","year":"2022","journal-title":"J Pharm Pract"},{"key":"2026091111365260200_qxag204-B62","author":"American Pharmacists Association"}],"container-title":["Health Affairs Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/advance-article-pdf\/doi\/10.1093\/haschl\/qxag204\/70514797\/qxag204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/9\/qxag204\/70514797\/qxag204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/9\/qxag204\/70514797\/qxag204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:36:58Z","timestamp":1789141018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article\/doi\/10.1093\/haschl\/qxag204\/8753775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/haschl\/qxag204","relation":{},"ISSN":["2976-5390"],"issn-type":[{"value":"2976-5390","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,7]]},"article-number":"qxag204"}}